Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2

A combined genome-wide association and linkage study was used to identify loci causing variation in cystic fibrosis lung disease severity. We identified a significant association (P = 3.34 × 10−8) near EHF and APIP (chr11p13) in p.Phe508del homozygotes (n = 1,978). The association replicated in p.Phe508del homozygotes (P = 0.006) from a separate family based study (n = 557), with P = 1.49 × 10−9 for the three-study joint meta-analysis. Linkage analysis of 486 sibling pairs from the family based study identified a significant quantitative trait locus on chromosome 20q13.2 (log10 odds = 5.03). Our findings provide insight into the causes of variation in lung disease severity in cystic fibrosis and suggest new therapeutic targets for this life-limiting disorder.

[1]  D. Schoeller,et al.  Energy intake and energy expenditure among children with polymorphisms of the melanocortin-3 receptor. , 2009, The American journal of clinical nutrition.

[2]  K. Rosendahl,et al.  Resting energy expenditure and lung disease in cystic fibrosis. , 2002, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  Stanley F. Nelson,et al.  Disease Gene Characterization through Large-Scale Co-Expression Analysis , 2009, PloS one.

[4]  Y. Lee,et al.  A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. , 2002, The Journal of clinical endocrinology and metabolism.

[5]  Christoph Lange,et al.  Variants in FAM13A are associated with chronic obstructive pulmonary disease , 2010, Nature Genetics.

[6]  M. Corey,et al.  A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies , 2011, Pediatric pulmonology.

[7]  A. Butler.  The melanocortin system and energy balance , 2006, Peptides.

[8]  B. Kerem,et al.  Correlation between genotype and phenotype in patients with cystic fibrosis. , 1994, The New England journal of medicine.

[9]  A. Hofman,et al.  Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function , 2010, Nature Genetics.

[10]  L. Almasy,et al.  Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.

[11]  Joshua T. Burdick,et al.  In silico method for inferring genotypes in pedigrees , 2006, Nature Genetics.

[12]  T. Libermann,et al.  Constitutive and cytokine-induced expression of the ETS transcription factor ESE-3 in the lung. , 2002, American journal of respiratory cell and molecular biology.

[13]  Don Kelly.  Hotel Dieu Hospital , 1910 .

[14]  M. Corey,et al.  Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. , 1997, The Journal of pediatrics.

[15]  A. Mushegian,et al.  The Epithelium-specific ETS Protein EHF/ESE-3 Is a Context-dependent Transcriptional Repressor Downstream of MAPK Signaling Cascades* , 2001, The Journal of Biological Chemistry.

[16]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[17]  Toshiyuki Yamada,et al.  Molecular biology of the Ets family of transcription factors. , 2003, Gene.

[18]  Mark D Schluchter,et al.  Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients , 2002, Statistics in medicine.

[19]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[20]  E. Chilvers,et al.  Prolonged survival of neutrophils from patients with ΔF508 CFTR mutations , 2008, Thorax.

[21]  Thomas T. Pace.  California Pacific Medical Center , 1992 .

[22]  T. Libermann,et al.  ESE-3, a Novel Member of an Epithelium-specific Ets Transcription Factor Subfamily, Demonstrates Different Target Gene Specificity from ESE-1* , 2000, The Journal of Biological Chemistry.

[23]  R. Simon,et al.  Cloning of a Novel Apaf-1-Interacting Protein: A Potent Suppressor of Apoptosis and Ischemic Neuronal Cell Death , 2004, The Journal of Neuroscience.

[24]  Michael R Knowles,et al.  Genetic modifiers of lung disease in cystic fibrosis. , 2005, The New England journal of medicine.

[25]  M. Corey,et al.  Complex two-gene modulation of lung disease severity in children with cystic fibrosis. , 2008, The Journal of clinical investigation.

[26]  M. Corey,et al.  Understanding the population structure of North American patients with cystic fibrosis , 2011, Clinical genetics.

[27]  K. Westerterp,et al.  Energy balance in cystic fibrosis when stable and during a respiratory exacerbation. , 2004, Clinical nutrition.

[28]  Larry Wasserman,et al.  Using linkage genome scans to improve power of association in genome scans. , 2006, American journal of human genetics.

[29]  Jonathan D. Campbell,et al.  Disease-specific reference equations for lung function in patients with cystic fibrosis. , 2005, American journal of respiratory and critical care medicine.

[30]  Theo Stijnen,et al.  Advanced methods in meta‐analysis: multivariate approach and meta‐regression , 2002, Statistics in medicine.

[31]  L. Leemis.  Applied Linear Regression Models , 1991 .

[32]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[33]  G. Cutting.  Modifier genes in Mendelian disorders: the example of cystic fibrosis , 2010, Annals of the New York Academy of Sciences.

[34]  T. Mak,et al.  Induced Inhibition of Ischemic/Hypoxic Injury by APIP, a Novel Apaf-1-interacting Protein* , 2004, Journal of Biological Chemistry.

[35]  Arthur Lucas,et al.  THE HOSPITAL FOR SICK CHILDREN , 1915, British medical journal.

[36]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[37]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[38]  D. Schoeller,et al.  Energy intake and energy expenditure among children with polymorphisms of the melanocortin-3 receptor 1 – 4 , 2009 .

[39]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[40]  J Blangero,et al.  Large upward bias in estimation of locus-specific effects from genomewide scans. , 2001, American journal of human genetics.

[41]  P. Vogt,et al.  Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Feinleib,et al.  Genetic and environmental influences on pulmonary function in adult twins. , 2015, The American review of respiratory disease.

[43]  Fred A. Wright,et al.  Integrated study of copy number states and genotype calls using high-density SNP arrays , 2009, Nucleic acids research.

[44]  A. Hamosh,et al.  Heritability of lung disease severity in cystic fibrosis. , 2007, American journal of respiratory and critical care medicine.

[45]  Shelley B Bull,et al.  Were genome‐wide linkage studies a waste of time? Exploiting candidate regions within genome‐wide association studies , 2010, Genetic epidemiology.

[46]  G. Abecasis,et al.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.

[47]  G. Fleming,et al.  Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis. , 2011, Glycobiology.

[48]  S. Nelson,et al.  Celsius: a community resource for Affymetrix microarray data , 2007, Genome Biology.

[49]  S. Randell,et al.  Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epithelium. , 2005, American journal of respiratory and critical care medicine.

[50]  G. Mcclearn,et al.  Genetic and environmental influences on pulmonary function in aging Swedish twins. , 1994, Journal of gerontology.

[51]  David Wypij,et al.  Pulmonary function between 6 and 18 years of age , 1993, Pediatric pulmonology.

[52]  C. Cho,et al.  Suppression of hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2 , 2007, Oncogene.

[53]  H. Heijerman,et al.  Correlation between genotype and phenotype in patients with cystic fibrosis. , 1994, The New England journal of medicine.

[54]  Scott T. Weiss,et al.  A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study , 2009, PLoS genetics.

[55]  Radu V. Craiu,et al.  Stratified false discovery control for large‐scale hypothesis testing with application to genome‐wide association studies , 2006, Genetic epidemiology.

[56]  Jing Wu,et al.  Regulation of epithelium-specific Ets-like factors ESE-1 and ESE-3 in airway epithelial cells: potential roles in airway inflammation , 2008, Cell Research.

[57]  P. Grieco,et al.  A role for MC3R in modulating lung inflammation. , 2008, Pulmonary pharmacology & therapeutics.

[58]  E. Golemis,et al.  CAS proteins in normal and pathological cell growth control , 2010, Cellular and Molecular Life Sciences.

[59]  K. Shianna,et al.  A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci , 2009, PLoS genetics.

[60]  Erica A. Golemis,et al.  HEF1-Dependent Aurora A Activation Induces Disassembly of the Primary Cilium , 2007, Cell.

[61]  G. Abecasis,et al.  Family-based association tests for genomewide association scans. , 2007, American journal of human genetics.

[62]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[63]  Inês Barroso,et al.  Genome-wide association study identifies five loci associated with lung function , 2010, Nature Genetics.

[64]  T. Nikolskaya,et al.  A comprehensive functional analysis of tissue specificity of human gene expression , 2008, BMC Biology.